#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3466	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1942	339.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1345	1345	C	334	C	207	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3466	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1942	339.5	0	HET	.	.	.	C451T	.	451	451	C	612	612	C	314	C,T	109,92	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3466	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1942	339.5	0	HET	.	.	.	G421A	.	421	421	G	582	582	G	301	G,A	159,44	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3466	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1942	339.5	0	HET	.	.	.	C207T	.	207	207	C	368	368	C	292	C,T	157,31	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	0	.	n	.	0	T695C	SNP	695	695	T	1336	1336	C	440	C	261	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2612	2612	C	297	C	186	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2686	2686	A	329	A	214	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3238	3238	C	363	C	229	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	0	HET	.	.	.	C1811T	.	1811	1811	C	2452	2452	C	388	C,T	166,75	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6590	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3706	335.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2279	2279	A	334	A,G	170,47	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	194	folP	855	855	100.0	folP.l15.c4.ctg.1	1406	26.8	1	SNP	p	R229S	1	.	.	685	687	AGC	937	939	AGC	26;26;27	A;G;C	18;18;18	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3503	37.0	1	SNP	p	S91F	1	.	.	271	273	TTC	459	461	TTC	38;38;38	T;T;C	22;21;22	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3503	37.0	1	SNP	p	G95N	0	.	.	283	285	GGC	471	473	GGC	40;40;40	G;G;C	23;23;23	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3503	37.0	1	SNP	p	D95G	1	.	.	283	285	GGC	471	473	GGC	40;40;40	G;G;C	23;23;23	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	192	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1382	28.5	1	SNP	p	G45D	0	.	.	133	135	GGC	329	331	GGC	64;64;64	G;G;C	39;39;39	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	146	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	888	30.0	0	.	n	.	0	A197.	DEL	197	197	A	479	479	A	70	A	44	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	546	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	34.2	1	SNP	p	D86N	0	.	.	256	258	GAC	674	676	GAC	57;57;60	G;A;C	36;33;37	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	546	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	34.2	1	SNP	p	R87I	0	.	.	259	261	CGT	677	679	CGT	60;60;61	C;G;T	37;38;37	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	546	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	34.2	1	SNP	p	R87W	0	.	.	259	261	CGT	677	679	CGT	60;60;61	C;G;T	37;38;37	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	546	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	34.2	1	SNP	p	S87R	1	.	.	259	261	CGT	677	679	CGT	60;60;61	C;G;T	37;38;37	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	546	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	34.2	1	SNP	p	S88P	0	.	.	262	264	TCC	680	682	TCC	61;61;61	T;C;C	37;38;38	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	436	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2885	29.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1658	1660	GGC	22;22;22	G;G;C	14;14;15	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1380	1382	GCC	80;80;80	G;C;C	48;47;48	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1383	1385	ATG	79;79;79	A;T;G	47;46;47	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1395	1397	ACC	84;84;84	A;C;C	50;51;49	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1395	1397	ACC	84;84;84	A;C;C	50;51;49	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1896	1898	ACC	44;44;44	A;C;C	24;26;28	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1950	1952	GCG	47;49;49	G;C;G	28;26;29	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1950	1952	GCG	47;49;49	G;C;G	28;26;29	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2073	2075	GGT	33;32;32	G;G;T	20;19;17	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2082	2084	AGC	25;24;24	A,C;G,A;C	14,1;16,1;15	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2337	47.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2100	2102	CCG	27;27;27	C;C;G	15;18;14	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1204	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3238	65.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1760	1762	CCG	21;21;22	C;C;G	11;14;12	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	338	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1867	35.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	23	C	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1725	40.4	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	393	395	CAG	30;28;28	C;A;G	19;17;19	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1725	40.4	1	SNP	p	G120K	1	.	.	358	360	AAG	633	635	AAG	44;45;45	A;A;G	28;30;27	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1725	40.4	1	SNP	p	A121N	1	.	.	361	363	AAC	636	638	AAC	45;45;45	A;A;C	29;31;28	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1725	40.4	1	SNP	p	N121D	0	.	.	361	363	AAC	636	638	AAC	45;45;45	A;A;C	29;31;28	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1610	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5147	59.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	969	29.4	1	SNP	p	V57M	1	.	.	169	171	ATG	493	495	ATG	47;47;49	A;T;G	30;31;32	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
